Occidental Petroleum Corp (OXY) 73.20 $OXY Occidental

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Occidental Petroleum Corp (OXY) 73.20 $OXY

Occidental (OXY) Reports Narrower-than-Expected Q2 Loss
Anwesha Chatterjee - Zacks Investment Research - 1 hr 17 mins ago
Occidental Petroleum Corporation (OXY) reported second-quarter 2016 loss of 18 cents per share, narrower than the Zacks Consensus Estimate of a loss of 20 cents
HES: 52.61 (+0.86), COP: 39.87 (+0.08), OXY: 73.20 (+0.08), APC: 52.08 (+0.45)

Occidental Petroleum (OXY) Q2 Loss Narrower-Than-Expected
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 7:36AM CDT
Occidental Petroleum (OXY) reported second quarter loss narrower than expected. Our consensus called for second-quarter loss of 20 cents, and the company reported loss of 18 cents
OXY: 73.20 (+0.08)

Occidental Petroleum Announces 2nd Quarter 2016 Results
BusinessWire - Wed Aug 03, 6:00AM CDT
Occidental Petroleum Corporation (NYSE:OXY) today announced its second quarter 2016 financial results on its website, www.oxy.com. The announcement and financial schedules can be accessed via the investor relations section of the website. The earnings release is also available on the Securities and Exchange Commission's website at www.sec.gov. The company will hold a conference call at 10 a.m. Eastern today. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors.
OXY: 73.20 (+0.08)

Key Energy Stock Earnings to Watch This Week: APA, CHK, OXY
Eric Dutram - Zacks Investment Research - Tue Aug 02, 3:30PM CDT
With oil price volatility still the name of the game, how are energy stocks expected to do this earnings season? We take a look at three of the most important which are reporting this week for some clues.
CHK: 4.98 (+0.08), APA: 50.55 (+0.61), OXY: 73.20 (+0.08)

Watch for Occidental Petroleum to Potentially Rebound After Falling 1.30% Yesterday
Comtex SmarTrend(R) - Tue Aug 02, 2:07PM CDT
Occidental Petroleum (NYSE:OXY) traded in a range yesterday that spanned from a low of $72.63 to a high of $74.08. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $73.25 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
OXY: 73.20 (+0.08)

Occidental Petroleum Set to Possibly Rebound After Yesterday's Selloff of 1.30%
Comtex SmarTrend(R) - Tue Aug 02, 2:05PM CDT
Occidental Petroleum (NYSE:OXY) traded in a range yesterday that spanned from a low of $72.63 to a high of $74.08. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $73.25 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
OXY: 73.20 (+0.08)

Why Earnings Season Could Be Great for Occidental Petroleum (OXY)
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 7:30AM CDT
Investors are always looking for stocks that are poised to beat at earnings season and Occidental Petroleum Corporation (OXY) may be one such company
OXY: 73.20 (+0.08)

Occidental Petroleum (OXY): Stock to Beat in Q2 Earnings?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:49AM CDT
In the second quarter, oil prices rebounded from two-year lows, which will likely drive Occidental Petroleum's (OXY) bottom line
DVN: 37.13 (+1.01), NOG: 3.63 (+0.19), CHK: 4.98 (+0.08), OXY: 73.20 (+0.08)

Occidental Petroleum (OXY) Announces 1.3% Dividend Hike
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 9:15AM CDT
The board of directors of Occidental Petroleum Corporation (OXY) has approved a 1.3% increase in its quarterly dividend rate
COP: 39.87 (+0.08), MRO: 13.08 (+0.18), OXY: 73.20 (+0.08), BHI: 47.01 (+0.33)

Occidental Petroleum Announces Dividend
BusinessWire - Thu Jul 14, 11:51AM CDT
Occidental Petroleum Corporation (NYSE:OXY) announced today that its Board of Directors has authorized an increase of the company's dividend to an annual rate of $3.04 per share, from the previous annual rate of $3.00 per share.
OXY: 73.20 (+0.08)

Occidental Petroleum Rises 1.53% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Jul 12, 2:32PM CDT
Occidental Petroleum (NYSE:OXY) traded in a range yesterday that spanned from a low of $76.66 to a high of $77.50. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $76.82 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OXY: 73.20 (+0.08)

Occidental Petroleum Set to Possibly Pullback After Yesterday's Rally of 1.53%
Comtex SmarTrend(R) - Tue Jul 12, 2:30PM CDT
Occidental Petroleum (NYSE:OXY) traded in a range yesterday that spanned from a low of $76.66 to a high of $77.50. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $76.82 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OXY: 73.20 (+0.08)

Occidental Petroleum 2nd Quarter Results to be Announced Wednesday, August 3, 2016
BusinessWire - Thu Jul 07, 8:00AM CDT
Occidental Petroleum Corporation (NYSE:OXY) will hold a conference call on Wednesday, August 3, 2016, at 10 a.m. Eastern, following the release of its second quarter 2016 financial results.
OXY: 73.20 (+0.08)

Watch for Occidental Petroleum to Potentially Pullback After Gaining 1.64% Yesterday
Comtex SmarTrend(R) - Mon Jun 20, 2:55PM CDT
Occidental Petroleum (NYSE:OXY) traded in a range yesterday that spanned from a low of $75.70 to a high of $76.44. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $75.34 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OXY: 73.20 (+0.08)

SmarTrend Watching for Potential Pullback in Shares of Occidental Petroleum After 1.64% Gain
Comtex SmarTrend(R) - Mon Jun 20, 2:54PM CDT
Occidental Petroleum (NYSE:OXY) traded in a range yesterday that spanned from a low of $75.70 to a high of $76.44. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $75.34 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OXY: 73.20 (+0.08)

Watch for Shares of Occidental Petroleum (OXY) to Approach Resistance at $75.11
Comtex SmarTrend(R) - Fri Jun 17, 8:37AM CDT
Shares of Occidental Petroleum (NYSE:OXY) opened today above their pivot of $74.30 and have already reached the first level of resistance at $74.78. Should the shares continue to rise, the resistance pivots of $75.11 and $75.92 will be of interest.
OXY: 73.20 (+0.08)

Downgrade Alert for Occidental Petroleum (OXY)
Comtex SmarTrend(R) - Tue Jun 14, 3:06AM CDT
Occidental Petroleum (NYSE:OXY) was downgraded from Overweight to Equal Weight at Morgan Stanley today. The stock closed yesterday at $75.25 on volume of 5.1 million shares, above average daily volume of 3.8 million. In the past 52 weeks, shares of Occidental Petroleum have traded between a low of $58.24 and a high of $82.02 and closed yesterday at $75.25, which is 29% above that low price. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 0.6%.
OXY: 73.20 (+0.08)

Stock Market News for June 08, 2016
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 9:10AM CDT
Benchmarks closed mostly in the green on Tuesday following gains in energy stocks
BIIB: 316.09 (-14.02), VRTX: 100.93 (+1.79), PXD: 162.80 (+3.22), ALXN: 137.03 (+3.42), HAL: 42.65 (+0.59), EOG: 80.97 (+1.08), AMGN: 173.09 (-1.06), ILMN: 165.18 (-1.74), XOM: 87.00 (-0.04), COP: 39.87 (+0.08), JUNO: 30.93 (+0.25), CVX: 99.93 (+0.34), OXY: 73.20 (+0.08), REGN: 436.62 (+1.72)

Occidental Petroleum (OXY) Breaks Through Resistance at $75.99
Comtex SmarTrend(R) - Tue Jun 07, 8:40AM CDT
Occidental Petroleum (NYSE:OXY) has opened bullishly above the pivot of $75.60 today and has reached the first level of resistance at $75.99. Investors may be interested in a cross of the next upside pivot targets of $76.56 and $77.52.
OXY: 73.20 (+0.08)

After Yesterday's Rally of 1.00% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Jun 06, 1:35PM CDT
Occidental Petroleum (NYSE:OXY) traded in a range yesterday that spanned from a low of $75.35 to a high of $76.18. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $75.72 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OXY: 73.20 (+0.08)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading